Tizanidine

Product NDC
71610-345
11-digit product format
716100345
Labeler code
71610
Product ID
71610-345_3bf538d4-6ba2-4d28-a7a7-02dc45819d30
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Tizanidine
Dosage form
TABLET
Route
ORAL
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Application
ANDA076416
Marketing category
ANDA
Marketing start
2015-07-28
Marketing end
0000-00-00
Substance
TIZANIDINE HYDROCHLORIDE
Active strength
2 mg/1
Pharmacologic classes
Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
NDC exclude flag
No
Listing certified through
2020-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
a0ff02d8-b711-423c-b7d1-ada00d81c743Product name120250805
9fd28b3a-d1bb-a2ce-ffa3-c3dd28536a01Product name820250313
b404127e-1c01-47bb-874e-db1e0b6bd9afProduct name420250313

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
71610-345-09Tizanidine9000 in 1 BOTTLETABLET90001

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
71610-345TIZANIDINE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]1Legacy NDC, 1 package rows20191017_df8afbf5-c83a-4149-a63c-5e8245055204.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
313412tiZANidine HCl 2 MG Oral TabletPSNdf8afbf5-c83a-4149-a63c-5e82450552041
313412tizanidine 2 MG Oral TabletSCDdf8afbf5-c83a-4149-a63c-5e82450552041
313412tizanidine 2 MG (as tizanidine HCl 2.288 MG) Oral TabletSYdf8afbf5-c83a-4149-a63c-5e82450552041

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
71610-345-09716100345099000 TABLET in 1 BOTTLE (71610-345-09) 9000 tablet2019-09-230000-00-00NoNoCurrent